City Therapeutics Builds Rnai Pipeline With $99.5M Series B
08 Jun 2026 //
BIOSPACE
How To Shine As Biotech Comes Back From The Brink
21 May 2026 //
BIOSPACE
City Therapeutics Presents RNAi Data for Stargardt at ARVO
06 May 2026 //
BUSINESSWIRE
City Therapeutics Files CTA for CITY-FXI RNAi Therapy
10 Nov 2025 //
BUSINESS WIRE
AN Venture Partners Announces Final Close of $200M Fund I
02 Jul 2025 //
BUSINESSWIRE
Biogen and City Therapeutics Partner on RNAi-based Therapies
27 May 2025 //
GLOBENEWSWIRE
City Therapeutics Expands Executive Team and Board of Directors
17 Apr 2025 //
BUSINESSWIRE

Market Place
Sourcing Support